22ND CENTURY GROUP
22nd Century Group is a plant biotechnology company developing tobacco harm reduction and smoking cessation products. In 1998, Joseph Pandolfino founded 22nd Century Limited, LLC (22nd Century) to provide funding to North Carolina State University (NCSU) for research and development collaboration on nicotine biosynthesis in the tobacco plant. Mr. Pandolfino questioned, coffee without caffeine and beer without alcohol is commercially available so why arenโt tobacco cigarettes without nicotine ... a choice for consumers? Further, he hypothesized: If it were possible to produce tobacco cigarettes without nicotine, smokers could use these extraordinary cigarettes to successfully quit smoking. A paradox to be sure. Nonetheless, Mr. Pandolfinoโs hypothesis stemmed from his careful observation of real smokers. As an importer of tobacco-free herbal cigarettes, Mr. Pandolfino had come to realize that some consumers were using nicotine-free herbal cigarettes to successfully quit smoking. Anecdotal evidence suggested that this approach was actually effective. The biggest problem with the novel โtherapyโ was the fact that herbal cigarettes have distinct taste and aroma characteristics which greatly limit their consumer appeal and acceptance. Indeed, although various processes were developed to improve these nicotine-free herbal cigarettes, it became clear that their peculiar taste and aroma characteristics would never appeal to mainstream smokers. If, on the other hand, a tobacco cigarette without nicotine could be developed, Mr. Pandolfino believed a new cigarette category could prove an attractive product choice to all smokers. With this in mind, Mr. Pandolfino set out to investigate the feasibility of efficiently producing tobacco cigarettes without nicotine.
22ND CENTURY GROUP
Industry:
Biotechnology Health Care Health Diagnostics
Founded:
1998-01-01
Address:
Clarence, New York, United States
Country:
United States
Website Url:
http://www.xxiicentury.com
Total Employee:
11+
Status:
Active
Contact:
716-270-1523
Email Addresses:
[email protected]
Total Funding:
111.74 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager Content Delivery Network Google Universal Analytics Domain Not Resolving
Similar Organizations
Advanced Cell Diagnostics
Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.
Celator Pharmaceuticals
Celator Pharmaceuticals is a biopharmaceutical company developing therapies to treat cancer, using the drug ratio technology platform.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Human Longevity
Human Longevity is a genomic-based, health intelligence company empowering proactive healthcare and enabling a life better lived.
Stemline Therapeutics
Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
Date | Company | Article | Price |
---|---|---|---|
2022-05-13 | GVB Biopharma | GVB Biopharma acquired by 22nd Century Group | 55 M USD |
Investors List
Crede CG III LTD
Crede CG III LTD investment in Post-IPO Equity - 22nd Century Group
Official Site Inspections
http://www.xxiicentury.com Semrush global rank: 1.37 M Semrush visits lastest month: 21.03 K
- Host name: 109.150.40.45.host.secureserver.net
- IP address: 45.40.150.109
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260